#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuromyelitis optica spectrum disorder Ureteric cancer Polycythaemia vera Neonatal alloimmune thrombocytopenia Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Extraskeletal ossification Hairy cell leukaemia Rett syndrome Homocystinuria Desmoid tumour Non-Hodgkin's lymphoma Cardiac sarcoidosis Netherton's syndrome Hormone-dependent prostate cancer Bile acid synthesis disorder More trials…

    Learn about Rare Diseases

    Idiopathic pulmonary fibrosis – Diagnostics Breast angiosarcoma Burkitt’s lymphoma – Basic Information Basal cell naevus syndrome – Treatment Angiosarcoma non-metastatic – Trials in Disease Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Fragile X syndrome – Treatment Krabbe’s disease Lymphatic malformation – Diagnostics Methylmalonic acidaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bemnifosbuvir Hemisulfate Alx148 Gs-5718-03 Abelacimab Methylone Sacubitril Abbv-668 Treg02 Pegenzileukin Alfacalcidol Rp1 Rbl007.2 Gsk3915393 IBUZATRELVIR MB-CART2219.1 Poa Pratensis Pollen Extract SULBACTAM SODIUM L-SERINE INCB123667 Auto4 More therapies…

    Learn about Your Condition

    Anal cancer Thrombotic microangiopathy Exudative retinopathy Anal cancer stage II Laryngeal leukoplakia Cystic fibrosis lung Decreased appetite Erythema Skin papilloma Cleft lip and palate Femur fracture Thymoma malignant Haematological infection Acoustic neuroma Injection site pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dementia

  • Using [18F]DED PET imaging to study brain changes in patients with Alzheimer’s disease, CADASIL, and other forms of dementia.

    Recruiting

    2 1 1
    Investigated Diseases:
    • CADASIL
    • Prodromal Alzheimer’s disease
    • Dementia
    Investigated Drugs:
    • [18F]DED
    Spain

  • Evaluating the effect of recombinant varicella zoster virus glycoprotein E on the risk of dementia in adults aged 76 years and older

    Recruiting

    3 1 1
    Investigated Drugs:
    • Recombinant Varicella Zoster Virus Glycoprotein E
    Finland

  • Study on the Accuracy of Tau PET ([18F]RO6958948) and Vizamyl (Flutemetamol 18F) in Diagnosing Mild Cognitive Symptoms and Risk of Alzheimer’s Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    • Prodromal Alzheimer’s disease
    • Dementia with Lewy bodies
    Investigated Drugs:
    • 2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3′,4′-D]Pyrrole
    • Flutemetamol (18F)
    Sweden

  • Title: Evaluation of lorazepam, pregabalin, and olanzapine in treating agitated behavior in dementia patients who did not respond to standard treatments

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dementia
    Investigated Drugs:
    • Lorazepam
    • Pregabalin
    • Fluoxetine Hydrochloride
    The Netherlands

  • Study on the Benefits of Amyloid PET Imaging with Florbetaben (18F) and Flutemetamol (18F) for Patients with Various Types of Dementia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Flutemetamol (18F)
    • Florbetaben (18F)
    Germany

  • Study on the Use of Flortaucipir for Diagnosing Mild Cognitive Impairment and Dementia in Patients

    Recruiting

    4 1 1
    Investigated Diseases:
    • Cognitive disorder
    • Dementia
    Investigated Drugs:
    • Flortaucipir (18F)
    The Netherlands
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!